February 22, 2021

Paragonix Announces First-in-Man use of LUNGguard™ Donor Lung Preservation System by Duke Hospital

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-man clinical use of the only FDA cleared cold storage device for donor lungs, its LUNGguard™ Donor Lung Preservation System, by Duke University Hospital. “Donor lungs are sensitive to injury and the current ice storage of lungs risks cellular injury, especially with the increasing transport distances and times now experienced by lung transpl


Leave Comment


Your Name *
Your Email *
Your Website
Comment *